Vaccinoprophylaxis of Hepatitis B N.A
https://doi.org/10.31631/2073-3046-2015-14-2-87-95
Abstract
The review summarizes the WHO materials and recommendations the latest editions of the official guidelines of the Ministries of Health Australia, Canada, Great Britain, Germany, Russia, USA, through the vaccination of viral hepatitis B. Special attention is paid to the immunization of persons belonging to the group of increased risk of the infection, the implementation of which is not fully defined in relation to native normative documents: the immunocompromise, hemodialyse, diabetic patients and healthscare personel.
About the Authors
N. A. Ozeretskovsky
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
N. V. Shalunova
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
E. M. Petruchuk
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
I. N. Indikova
Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products» of the Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
References
1. Mast E., Word J. Hepatitis B vaccines. Vaccines, 5 ed. Ed.: S. Plotkin, W. Orenstain, P. Offit, Sanders Elsevier. 2012; 205 – 245.
2. Recommendations to assure the quality, safety and efficacy of recombinant hepatitis B vaccines. WHO Technical Report Series. 2013; 978.
3. Pocket Guide to Hepatitis B. The Wisconsy School of Medicine and Public Health. 2009: 16 – 19.
4. Complete List of Vaccines Licenced for immunization and Distribution in the US available at /www.fda.gov/BiologicalsBlood Vaccines/Vaccines/Aproved-Products.
5. Hepatitis B Vaccine. Position Paper WHO. Weekly epidemiological record. 2009; 84. (40): 405 – 420.
6. Hepatitis B. Green Book. Immunization against Infectious Diseases. 2013; 2: 161 – 184.
7. Hepatitis B Vaccine. Canadian Immunization Guide. 2012 part 4. Active Vaccines. Available at: //www.Phac–aspc.gc.co/public at/cig–gci/po4–heb–eng.
8. Russian Federation National Immunization Schedule. Rossiiskaya Gazeta may 16 2014. № 109 (6381) (in Russian)
9. Hepatitis B.The Red Book. Report of the Committee on Infectious Diseases. American Academy of Pediatrics. 2012; 29 ed.: 369 – 390.
10. Global routine vaccination сoverage 2013. Weekly epidemiological record. 21 Nov. 2014; 47 (89): 517 – 528.
11. Hepatitis B Vaccination in Europe. The Health Protection Surveillance Centre. European Centre for Disease Control. November 2008–March 2009: 12 – 23.
12. Hepatitis B. Australian Immunization Handbook. 2013. 10 ed., part 4 – 5: 208 – 231.
13. CDC Recommended Immunization Schedule persons age 0 through 18 Years. United States 2014. MMWR 2013; 62 (1): 2 – 8.
14. ACIP. Vaccines for Children Program. Hepatitis B. Resolution. October 16. 2003; 10/03-2.
15. Hepatitis B Vaccine. CDC. Epidemiology and Prevention of Vaccine- Preventable Diseases. The Pink Book. 2012; 12 ed.: 115 – 133.
16. The National Immunization Program Schedule Guidelines for preventive effectivities in general practice. 8 ed. 2012; 6.1. Immunization: 34 – 37.
17. EMRO. Vaccine-preventable diseases and immunization; Immunization safety in WHO regions. WHO position papers. Recommendation for routine immunization& Available at: //www.who.int/vaccine.Safety/en/
18. A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B in the United States. Recommendation of ACIP. MMWR. Dec. 8. 2006; 55. RR-16: 1 – 25.
19. WHO. Immunization, Vaccines and Biologicals. The Immunological Basis for Immunization Series. 2011. Module 22: Hepatites B: 9.
20. WHO. MMC. Hepatites B. Information Bulletin. July 2013; 204. (in Russian)
21. Summary of Notifiable Diseases-United States. 2012. MMWR& Sept. 19 2014; 61 (53).
22. The State Report «Sanitary-epidemiological welfave of Russion Federation population in 2013» Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. 2014 (in Russian).
23. Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. The Information about Infection and Parasital Diseases for January-December 2013 (in Russian)
24. Use of Hepatites B vaccination for adults with diabetes mellitus: recommendation of the advisorу cоmmittee on immunization practicies MMWR. Dec. 2011; 60 (50): 1709 – 1711.
25. Medlain Abstract for Hepatitis B vaccination. Аvailable at: //www.upto date.com©2014 UptoDate
26. American Diabetes Association. Standarts of medical care in diabetes. 2013. Diabetes Care. 2013; 36: 11 – 66.
27. Huang J. Нераtitis В vaccination reduces the risкs of diabetes bу 50%. American Diabetic Associacion Scientific Session. June 2014. San Francisco 13–17 June. Рharmacy Learning Network. June 24. 2014.
28. CDC. Viral Hepatitis Specific Setting. Hemodialysis and Viral Hepatitis. Hepatitis B. Vaccination and Testing. 30. СDС. Hemodialуsis and Viral Hepatitis, 2013 Available at: //www.cdc.gov/hepatitis/Settings/Неmo.htm.
29. CDC. Guidelines for vaccinating kidney dialysis patient and patients with cronic kidney disease. Dec. 2012: 4 – 6.
30. СDС. Hemodialуsis and viral hepatitis, 2013. Аvailable at: //www.cdc.gov/hepatitis/Settings/Неmo.htm.
31. WHO. The immunological basis for immunization series.. Module 22: Hepatitis B. WHO. Immunization Vaccines and Biologicals. 2011.
32. British HIV Association guidelines for immunization of HIV-infected adults, 2007.7.0 Hepatitis B. HIV Medicine. 2008; 9 (4): 807 – 810.
33. Rubin L., Levin M., Ljungman Р. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised hosts. Clin. Infect. Dis. Fеb. 2014; 58 (3): 4 – 100.
34. Harder T., Remeschmidt C., Falkenhorst G. Background paper to revised recommendation for hepatitis B vaccination on persons at particulary risk and for hepatitis B postexposure prophylaxis in Germany. Bundesgesundheitsbott. 2013; 56: 1565 – 1576.
35. Recommendation of standing Committee on Vaccination (STIКО) аt Robert Косh Iinstitute. Ерidemiologisches Bulletin. Aug. 2013; 34: 341, 342.
36. CDC, Guidelines for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management. MMMR. Dec. 20. 2013; 62 (10): 1 – 19.
37. CDC. Possible side-effects from vaccines. Aug. 19. 2014. Available at: //www.cdc.gov/vaccines/vac-gen/side-effects.htm.
38. 38. WHO Global Advisorу Cоmmittee on Vaccine Safetу 1-2 December 2005. Weekly epidemiological record 13 Jan. 2006; 8: 13 – 20.
39. WHO Global Advisorу Cоmmittee on Vaccine Safety, 12 – 13, December 2007. Weakly epidemiological record 25 Nov. 2008; 83: 37 – 44.
40. WHO Global Advisorу Cоmmittee on Vaccine Safetу, 20-21, June 2002. Weakly epidemiological record 22 Nov. 2002; 77: 389 – 404.
41. Guide to vaccine contraindications and precautions.CDC, 2011. Available at: //www.cdc.gov/vaccines/recs/vac-admin/downloads/contraindicationsguide-508.
42. Status of vaccine research and development, 2012. The Jordan Report 2012, app. A: 162.
Review
For citations:
Ozeretskovsky N.A., Shalunova N.V., Petruchuk E.M., Indikova I.N. Vaccinoprophylaxis of Hepatitis B N.A. Epidemiology and Vaccinal Prevention. 2015;14(2):87-95. (In Russ.) https://doi.org/10.31631/2073-3046-2015-14-2-87-95
Views:
884
Email this article 